Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

Exxon Mobil Stock’s 8.7% Dividend Yield Reeks of Desperation

By Will Ashworth, InvestorPlace Contributor
Exxon Mobil’s dividend is currently yielding 8.7%. Does that make Exxon Mobil stock a buy? No, but not for the reason you might think.

It’s Best to Avoid Ocugen Stock at the Moment

By Ian Cooper, InvestorPlace Contributor
Until we begin to see solid trial results, OCGN stock could easily plunge back to 20 cents a share. Avoid investing in Ocugen for now.

It Makes No Sense to Buy Chesapeake Energy Shares

By Ian Cooper, InvestorPlace Contributor
There’s also no certainty of survival down the road for Chesapeake Energy stock – at least, not near term. Stay far away from the stock.

3 Gold Stocks That Are Quickly Losing Their Luster

By Muslim Farooque, InvestorPlace Contributor
Gold stocks have been on a tear of late, but not all stocks in the space have done well. Here are three that have struggled.

Steer Clear of Coronavirus Vaccine Also-Ran iBio Stock

By Thomas Niel, InvestorPlace Contributor
So, what's the play here? Too risky to go long (or short), stay far away vaccine play IBIO stock. Other vaccine candidates may offer opportunity. But, this "also-ran" isn't much of a contender.

Chesapeake Energy Stock Has No Real Hope for a Comeback

By Brad Moon, InvestorPlace Contributor
Chesapeake was staggered by the pandemic and an oil price war, and after bankruptcy Chesapeake Energy stock is a risky bet.

Whiting Will Exit Bankruptcy, But That Won’t Save Investors

By Ian Bezek, InvestorPlace Contributor
Whiting is set to leave bankruptcy over the next week. But don't count on a comeback for WLL stock, as shares will be nearly wiped out in the reorganization.

Buffett’s Sale of 100% of His Occidental Common Stock Is All Investors Need to Know

By Will Ashworth, InvestorPlace Contributor
Warren Buffett sold all of his Occidental Petroleum common stock in the second quarter. OXY stock appears to be a hopeless cause.

Without a Partner, iBio’s Gains Are Just a Fantasy

By Patrick Sanders, InvestorPlace Contributor
iBio is behind others in developing a Covid-19 vaccine and it doesn't have a FastPharming partner. There's diminishing value to IBIO stock.

3 Stocks to Short as Markets Climb Higher

By Tezcan Gecgil, InvestorPlace Contributor
Given the recent increases in their share prices and valuations, these three businesses top my list of stocks to short.

Whiting Petroleum Will Emerge From Bankruptcy Looking Weak

By Mark R. Hake, CFA
Whiting Petroleum will emerge from bankruptcy on Sept. 1 very weakened. Don't bother buying WLL stock until its future becomes clearer.

Right Now, There’s No Point in Trying to Catch Falling Knife Genius Brands Stock

By Thomas Niel, InvestorPlace Contributor
But, chances are the company struggles to break into the media oligopoly. Instead, expect more dilution, as the company raises cash to keep the lights on. Barring a second round of the "Robinhood effect," expect GNUS stock to keep on tumbling from here.

Marathon Patent Group Will Likely See $2 Before $5

By Tezcan Gecgil, InvestorPlace Contributor
MARA stock is a risky investment, as Marathon Patent Group will likely run into financial troubles in the quarters ahead.

3 Key Questions to Ask Before Buying Novavax

By Vince Martin, InvestorPlace Contributor
Vaccine approval certainly can drive NVAX stock back to new highs after a recent pullback. But risks go beyond vaccine development.

Mixed Messaging Leaves Under Armour Stock Floundering

By Josh Enomoto, InvestorPlace Contributor
Under Armour stock is floundering while its rivals are soaring. But this underperformance is no reason to bet heavily on this company.

Luckin’s Lack of Brand Appeal Hurts Its Comeback Story

By Josh Enomoto, InvestorPlace Contributor
Luckin stock might appeal to contrarians due to its rock-bottom prices. But you should never forget that there’s a reason why.

Inovio Stock Is a Sideshow, Not a Serious Investment

By Lou Carlozo, InvestorPlace Contributor
INO stock is putting vaccine news front and center -- in place of strong fundamentals. If you decide to take a chance, be aware -- it's a specuative on

Luckin Stock Is as Stale as Day Old Coffee

By Joel Baglole, InvestorPlace Contributor
Given the breadth and impact of its fraudulent accounting scandal, it looks unlikely that Luckin coffee will be able to recover and remain a going concern. Investors should play it smart and avoid Luckin stock. Money would be better spent on reliable coffee stocks such as Starbucks and Dunkin' Donuts.

Analysts Like Costco, but What’s Up with the Insider Selling?

By David Moadel, InvestorPlace Contributor
It's nice to know that the experts are bullish on Costco. Yet it's worrisome that some insiders are selling their Costco stock.
Load More Articles